OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
November 08, 2016
Idifarma has announced a growth of more than 50% over the past two years. Revenue is expected to hit approximately EUR5.3 million in 2016, growing from EUR3.5 million in 2014.
November 04, 2016
German biotech ARTES and Iranian biopharma manufacturer BioSun will develop an HPV vaccine.
November 02, 2016
This article will clarify reasonable expectations for the responsibilities of topical product formulation developers and for excipient suppliers regarding the information and samples for experiments needed for QbD.
Reliable, high-quality products require innovative analytics and production.
A lifecycle approach can be used to develop GMP-compliant cleaning procedures for continuous manufacturing of solid-dosage pharmaceuticals.
Shear-sensitive ingredients in a tableting formulation experience different conditions in a batch tumble blender than they would in a continuous paddle blender.
A dissolution method should have adequate discriminatory power to detect formulation changes that affect the dissolution rate of a drug product.
A variety of strategies have been employed to deliver proteins and peptides in improved parenteral formulations and/or via noninvasive routes.
Astellas will acquire Ganymed and its portfolio of ideal monoclonal antibody candidates.
The biosimilar pathway permits licensure based on less than full clinical data.